Alaska Permanent Fund logo

Alaska Permanent Fund

North America, Alaska, United States, Juneau

Description

The Alaska Permanent Fund is a constitutionally established permanent fund managed by a state-owned corporation, the Alaska Permanent Fund

Investor Profile

Alaska Permanent Fund has made 17 investments, with 0 in the past 12 months and 29% as lead.

Stage Focus

  • Series B (35%)
  • Series A (24%)
  • Series C (18%)
  • Series F (6%)
  • Series Unknown (6%)
  • Series E (6%)
  • Series D (6%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Medical
  • Health Care
  • Agriculture
  • Agtech
  • Farming
  • Greentech
  • Genetics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alaska Permanent Fund frequently co-invest with?

Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 4
CEAS Investments
North America, Florida, United States, Delray Beach
Co-Investments: 3
Altitude Life Science Ventures
North America, Colorado, United States, Durango
Co-Investments: 4
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 3
Bezos Expeditions
North America, District of Columbia, United States, Washington
Co-Investments: 2
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Yukon Partners
North America, Minnesota, United States, Minneapolis
Co-Investments: 2
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 13
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 8
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 3

Which angels does Alaska Permanent Fund often collaborate with?

KH
North America, California, United States, San Diego
Shared Deals: 1

What are some of recent deals done by Alaska Permanent Fund?

Kenai Therapeutics

San Diego, California, United States

Kenai Therapeutics focuses on developing therapies for neurodegenerative movement disorders.

BiotechnologyHealth CareMedicalTherapeutics
Series AFeb 29, 2024
Amount Raised: $82,000,000
Tessera Therapeutics

Cambridge, Massachusetts, United States

Tessera Therapeutics is a biotechnology company that focuses on a new category of genetic medicines.

BiopharmaBiotechnologyGeneticsLife ScienceTherapeutics
Series CApr 19, 2022
Amount Raised: $300,000,000
NorthLink Aviation

Anchorage, Alaska, United States

NorthLink Aviation is developing a world-class air cargo terminal at the Ted Stevens Anchorage International Airport.

AerospaceAir Transportation
Series UnknownDec 1, 2021
Generate Biomedicines

Somerville, Massachusetts, United States

Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.

BiotechnologyHealth CareMedicalProduct Research
Series BNov 18, 2021
Amount Raised: $370,000,000
Repertoire Immune Medicines

Cambridge, Massachusetts, United States

Repertoire Immune Medicines is a clinical stage biotechnology company.

BiotechnologyLife ScienceMedicalTherapeutics
Series BApr 13, 2021
Amount Raised: $189,000,000
Tessera Therapeutics

Cambridge, Massachusetts, United States

Tessera Therapeutics is a biotechnology company that focuses on a new category of genetic medicines.

BiopharmaBiotechnologyGeneticsLife ScienceTherapeutics
Series BJan 12, 2021
Amount Raised: $230,000,000
Indigo

Boston, Massachusetts, United States

Indigo is an agricultural technology company that focuses on improving sustainability and profitability in farming practices.

AgricultureAgTechFarmingGreenTech
Series FAug 3, 2020
Amount Raised: $360,000,000
Sana Biotechnology

Seattle, Washington, United States

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

BiotechnologyHealth CareLife ScienceProduct Research
Series AJun 23, 2020
Amount Raised: $700,000,000
Indigo

Boston, Massachusetts, United States

Indigo is an agricultural technology company that focuses on improving sustainability and profitability in farming practices.

AgricultureAgTechFarmingGreenTech
Series ESep 18, 2018
Amount Raised: $250,000,000
Codiak Biosciences

San Francisco, California, United States

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.

BiotechnologyMedicalTherapeutics
Series CNov 29, 2017
Amount Raised: $76,500,000